Results 61 to 70 of about 4,252 (213)

Development of an Anti-Zearalenone Nanobody Phage Display Library and Preparation of Specific Nanobodies

open access: yesCurrent Issues in Molecular Biology
Zearalenone (ZEN), a toxic estrogenic mycotoxin in cereals, threatens human and animal health through reproductive, immune, and cytotoxic effects, necessitating sensitive detection methods.
Ying Zeng   +9 more
doaj   +1 more source

Hierarchical Targeting of TREM2+ Myeloid Cells via Acid‐Triggered OMVs Reprogram Immunosuppression and Suppress Osteolysis in Bone‐Metastatic TNBC

open access: yesAdvanced Science, Volume 13, Issue 32, 9 June 2026.
This study developed a hierarchical targeting nanoplatform, siTREM2@ETP‐PEOz‐OMVs, against triple‐negative breast cancer (TNBC) bone metastasis. It precisely delivers therapeutic siTREM2 to monocytes/macrophages within the metastatic niche. This intervention dually regulates cell fate: reprogramming immunosuppressive macrophages and inhibiting ...
Fanglu Chen   +12 more
wiley   +1 more source

Enrichment of the phages in each round of biopanning.

open access: yes, 2013
Enrichment of the phages in each round of biopanning.
Lili Wang (104605)   +8 more
core   +1 more source

Propagation Capacity of Phage Display Peptide Libraries Is Affected by the Length and Conformation of Displayed Peptide

open access: yesMolecules, 2023
The larger size and diversity of phage display peptide libraries enhance the probability of finding clinically valuable ligands. A simple way of increasing the throughput of selection is to mix multiple peptide libraries with different characteristics of
Danna Kamstrup Sell   +3 more
doaj   +1 more source

Monitoring the progress of biopanning by polyclonal phage ELISA

open access: yes, 2015
. (A) The polyclonal phage mixture from each round of biopanning was tested for recognition of Gad m 1, Cyp c 1 and Onc m 1. (B) Monoclonal phage ELISA: Ten single phage clones randomly selected from each third round of biopanning were tested for binding
Klaus R. Liedl (109013)   +12 more
core   +1 more source

Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic Function

open access: yesAdvanced Science, Volume 13, Issue 36, 29 June 2026.
This review explains how Extracellular vesicles‐producing cells can be endogenously engineered to load therapeutic proteins and nucleic acids. We summarize physiological and genetic strategies that harness native sorting pathways for selective cargo loading.
Jinghui Wang   +10 more
wiley   +1 more source

Expansion and Refinement of Deep Sequence-Coupled Biopanning Technology for Epitope-Specific Antibody Responses in Human Serum

open access: yesViruses, 2020
Identifying the specific epitopes targeted by antibodies elicited in response to infectious diseases is important for developing vaccines and diagnostics.
Nikole L. Warner   +7 more
doaj   +1 more source

Design and Construction of a Synthetic Nanobody Library: Testing Its Potential with a Single Selection Round Strategy

open access: yesMolecules, 2023
Nanobodies (Nbs) are single domain antibody fragments derived from heavy-chain antibodies found in members of the Camelidae family. They have become a relevant class of biomolecules for many different applications because of several important advantages ...
María Angélica Contreras   +9 more
doaj   +1 more source

NS1 and E enriched epitopes identified by deep sequence-coupled biopanning with patient serum after two rounds of biopanning.

open access: yes, 2017
NS1 conservation (A) is shown for the highly enriched overlapping peptides from patient 1536 after two rounds of biopanning. Bold letters indicate the flanking amino acids that are solved in the crystal structure (see Fig 5F for structure).
Kathryn M. Frietze (3713686)   +4 more
core   +1 more source

Nanobodies: A Promising Toolkit for Diagnostic Applications

open access: yesSmartMat, Volume 7, Issue 3, June 2026.
This review focuses on camelid‐derived nanobodies (VHHs) and explains how their small size and high stability support robust diagnostic design. Applications across ELISA, lateral flow assays, and PET/SPECT imaging are summarized, along with clinical progress such as caplacizumab.
Wei Wu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy